API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 134 articles Forum Github 13 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. TIL.NASDAQ

Instil Bio Inc. (TIL NASDAQ) stock market data APIs

$73 8.02(12.3%) as of September 16, 2024
Price chart is built with Anychart

Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

Instil Bio Inc. Financial Data Overview

64.985
73
-
76.1279
58.88
6.07-92
550 M
6 504 K
0
-2.29
1.216
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'TIL',
Type: 'Common Stock',
Name: 'Instil Bio Inc.',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00ZGYN521',
ISIN: NULL,
CUSIP: NULL,
CIK: '1789769',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-03-19',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Instil Bio Inc. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -66 022 000
  • Earnings Per Share -18.39
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Instil Bio Inc. Earnings via APIs

  • Latest Release 2024-08-13
  • EPS/Forecast -2.98

Get Instil Bio Inc. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Instil Bio Inc. latest news via APIs

Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update

DALLAS, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, thera...
  • EARNINGS RELEASES AND OPERATING RESULTS
  • INSTIL BIO
  • NASDAQ:TIL

Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual Meeting

DALLAS, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, thera...
  • CALENDAR OF EVENTS
  • CLINICAL STUDY
  • HEALTH
  • INSTIL BIO
  • NASDAQ:TIL
  • TRADE SHOW
Do you have any questions?
support@eodhistoricaldata.com